Is Exponent, Inc. (EXPO) Overvalued?
We dive into why Exponent, Inc. (EXPO) could be considered overvalued on 2026-07-31, based on AAII’s Value Score and Grade.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
Commentary & Analysis
What You Need to Know About Exponent, Inc.'s Q3 Earnings
Exponent, Inc.'s fiscal Q3 earnings report was released on Thursday, July 30. Let's dive in to see if (EXPO) missed or beat analyst's expectations.Michael Rose
Why Exponent, Inc.’s (EXPO) Stock Is Down 5.49%
As of Wednesday, May 13, Exponent, Inc.’s EXPO share price has dipped by 5.49%, which has investors questioning if this is right time to buy.Michael Rose
What You Need to Know About Exponent, Inc.'s Q2 Earnings
Exponent, Inc.'s fiscal Q2 earnings report was released on Thursday, April 30. Let's dive in to see if (EXPO) missed or beat analyst's expectations.Michael Rose
Why Exponent, Inc.’s (EXPO) Stock Is Down 5.31%
As of Thursday, February 12, Exponent, Inc.’s EXPO share price has dipped by 5.31%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | EXPO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,338.2 | $1,135.7 | 60% |
|
| Shares Out (Mil) | 49.0 | 39.0 | 47% |
|
| Institutional Ownership | 98.8% | 87.3% | 82% |
|
| Float (Mil) | 46.9 | 34.7 | 46% |
|
| Beta | 0.68 | 0.77 | 40% |
|
| Avg Daily Volume (000s) | 369 | 425 | 53% |
|
| Price Change (52-week) |
0.3% | 69.7% | 44% |
|
| Growth | EXPO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.2% | 7.4% | 46% |
|
| Net Income (5yr) | 5.1% | 8.0% | 48% |
|
| EPS (5yr) | 6.0% | 11.8% | 40 |
|
| Dividends (5yr) | 9.6% | 0.0% | 82% |
|
| Cash Flow (5yr) | (30.8%) | (13.8%) | 18% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | $0.631 | $2.446 | $2.757 | |
| Month Ago EPS | $0.637 | $2.469 | $2.760 | |
| # Rev Up | 2 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.637 | $2.469 | $2.760 | |
| Year/Year Chg | 5.2% | 18.2% | 36.0% | |
| Financials | EXPO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $567 | $1,344 | 42% |
|
| Net Income (TTM) (Mil) | $112 | $37 | 62% |
|
| EPS (TTM) | $2.239 | $0.800 | 73% |
|
| Operating Cash Flow (TTM) (Mil) | $118 | $153 | 53% |
|
| Net Cash Flow (TTM) (Mil) | ($165) | $0 | 11% |
|
| Long-Term Debt (Q1) (Mil) | $74 | $214 | 42% |
|
| Enterprise Value (Q1) (Mil) | $3,190 | $1,666 | 55% |
|
| Valuation | EXPO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 11.57 | 2.65 | 91% |
|
| P/E | 31.5 | 24.3 | 70% |
|
| Dividend Yield | 1.8% | 0.0% | 75% |
|
| PEG (5yr hist) | 5.3 | 1.3 | 88% |
|
| Ratios | EXPO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 36.4% | 36.5% | 44% |
|
| Net Margin | 19.7% | 3.2% | 78% |
|
| ROA | 15.8% | 3.1% | 94% |
|
| ROE | 31.2% | 8.4% | 88% |
|
| Liabilities to Assets | 55.8% | 59.0% | 48% |
|
| F-Score | 8 | 5 | 93% |
|
Exponent, Inc. did not pass any screens on 8/21/2026.
